Safety and Performance of an Advanced Hybrid Closed-Loop (AHCL) Algorithm with Ultra-rapid Lispro (URLi) and Lispro

被引：1
|
作者：
Pollom, Robyn K.
Nosek, Leszek
Coester, Hans Veit
Zijlstra, Eric
Ghosh, Aritra
Haidar, Ahmad
Jones, Richard
Leohr, Jennifer
Gleissner, Stephanie E.
Dassau, Eyal
Katz, Michelle
机构：
来源：
DIABETES | 2023年 / 72卷
关键词：
D O I：
10.2337/db23-105-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
105-LB
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Ultra-Rapid Lispro (URLi) Showed Greater Reduction in Postprandial Glucose (PPG) vs. Humalog in Children, Adolescents, and Adult Patients with Type 1 Diabetes (T1D)
    Aronson, Ronnie
    Linnebjerg, Helle
    Leohr, Jennifer
    Labell, Elizabeth S.
    Coutant, David E.
    Zhang, Qianyi
    Danne, Thomas
    Pollom, Robyn K.
    DIABETES, 2020, 69
  • [42] Ultra-Rapid Lispro Efficacy and Safety Compared to Humalog® in Japanese Patients With Type 2 Diabetes: PRONTO-T2D Subpopulation Analysis
    Hideaki Jinnouchi
    Makoto Imori
    Hiroshi Nishiyama
    Takeshi Imaoka
    Diabetes Therapy, 2020, 11 : 2075 - 2088
  • [43] Ultra-Rapid Lispro Efficacy and Safety Compared to Humalog® in Japanese Patients with Type 1 Diabetes: PRONTO-T1D Subpopulation Analysis
    Junnosuke Miura
    Makoto Imori
    Hiroshi Nishiyama
    Takeshi Imaoka
    Diabetes Therapy, 2020, 11 : 2089 - 2104
  • [44] Ultra-Rapid Lispro Efficacy and Safety Compared to Humalog® in Japanese Patients With Type 2 Diabetes: PRONTO-T2D Subpopulation Analysis
    Jinnouchi, Hideaki
    Imori, Makoto
    Nishiyama, Hiroshi
    Imaoka, Takeshi
    DIABETES THERAPY, 2020, 11 (09) : 2075 - 2088
  • [45] RAPID IMPROVEMENT IN TIME IN RANGE AFTER ADVANCED HYBRID CLOSED-LOOP SYSTEM INITIATION
    Beato-Vibora, P. I.
    Gallego-Gamero, F.
    Ambrojo-Lopez, A.
    Gil-Poch, E.
    Martin-Romo, I.
    Carrasco-Munoz, M.
    Arroyo-Diez, F.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A79 - A79
  • [46] INDIRECT TREATMENT COMPARISON (ITC) OF ULTRA-RAPID LISPRO INSULIN (URLI) VERSUS FAST-ACTING INSULIN ASPART (FASTER ASPART) IN PATIENTS WITH TYPE 1 DIABETES (T1DM)
    Osumili, B.
    Paczkowski, R.
    Spaepen, E.
    Liao, B.
    Tobian, J.
    VALUE IN HEALTH, 2020, 23 : S506 - S507
  • [47] Ultra-Rapid Lispro Efficacy and Safety Compared to Humalog(R)in Japanese Patients with Type 1 Diabetes: PRONTO-T1D Subpopulation Analysis
    Miura, Junnosuke
    Imori, Makoto
    Nishiyama, Hiroshi
    Imaoka, Takeshi
    DIABETES THERAPY, 2020, 11 (09) : 2089 - 2104
  • [48] Robust Glycemic Outcomes after MiniMed Advanced Hybrid Closed-Loop (AHCL) System Use in the Pivotal Trial Regardless of Previous Therapy
    Shin, John
    Chen, Xiaoxiao
    Liu, Margaret
    Huang, Suiying
    Cordero, Toni L.
    Rhinehart, Andrew S.
    Vigersky, Robert
    DIABETES, 2021, 70
  • [49] Efficacy and Safety of Ultra-Rapid Lispro in Younger and Older Patients with Type 2 Diabetes: Randomized Double-Blind PRONTO-T2D Study
    Zhang, Qianyi
    Chigutsa, Farai
    Chang, Annette M.
    DIABETES THERAPY, 2022, 13 (08) : 1547 - 1557
  • [50] Efficacy and Safety of Ultra-Rapid Lispro in Younger and Older Patients with Type 2 Diabetes: Randomized Double-Blind PRONTO-T2D Study
    Qianyi Zhang
    Farai Chigutsa
    Annette M. Chang
    Diabetes Therapy, 2022, 13 : 1547 - 1557
12345